Lung cancer causes more deaths than the next 3 deadliest cancers combined.1

With our advanced CT technologies and expertise, we can help you lead your community in the fight against lung cancer.

Taking a stand against the number one cancer killer in the world is no small task, but the National Lung Screening Trial (NLST) showed a compelling 20% reduction in lung cancer mortality using low-dose CT screening1 in high risk patients, prompting the approval for screening reimbursement by the U.S. Preventive Services Task Force (USPSTF) and the Centers for Medicare and Medicaid Services (CMS).2,3

We're proud to be the first CT manufacturer with an indication for low-dose CT lung cancer screening.4 Using qualified GE CT scanners and our new low-dose CT lung cancer screening protocols, you can increase early detection in high-risk patients and help prevent a substantial number of lung cancer related deaths5

All new GE 64-slice and greater CT scanners and virtually all of our 16-slice CT scanners include the screening option and the option is also available to thousands of qualified GE CT scanners currently in use, increasing access for both patient and physician lung cancer screening needs.

GE low-dose CT lung cancer screening protocols are tailored to the CT system, patient size and the most current recommendations from a wide range of professional medical and governmental organizations.

Implementing a low-dose CT lung cancer screening program gives you the ability to change lives in your patient community but also has the potential to dramatically increase the demands of your radiology department and beyond. Are you ready? Contact us to find out how we can help.

Qualified Systems

Resources

References

  1. National Cancer Institute. Surveillance, Epidemiology and End Results Program (SEER). SEER Stat Fact Sheets: Lung and Bronchus Cancer. https://seer.cancer.gov/statfacts/html/lungb.html.
  2. The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.
  3. CMS has determined that those beneficiaries who are 55-77, asymptomatic, have a tobacco smoking history of at least 30 pack-years, are a current smoker or one who has quit smoking within the last 15 years; and receives a written order for LDCT lung cancer screening may receive an annual screening for lung cancer with low-dose computed tomography (LDCT), as an additional preventive service benefit under the Medicare program. CMS: Decision Memo for Screening for Lung Cancer with Low- Dose Computed Tomography (LDCT) (CAG-00439N).
  4. The Low-Dose CT (LDCT) Lung Cancer Screening Option (LCS) for qualified GE Systems is indicated for using low-dose CT for lung cancer screening. The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society.
  5. Moyer V. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;160:330-338. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening.
  6.  The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. https://www.nejm.org/doi/full/10.1056/NEJMoa1102873